Kinney Horn
Net worth: 711 250 $ as of 2026-07-30
Net worth: 711 250 $ as of 2026-07-30
Kinney Horn is currently Chief Business Officer at Immunome, Inc. since 2024.
Formerly, Mr. Horn was Chief Business Officer at Olema Pharmaceuticals, Inc. from 2020 to 2023 and Director-Business Development at Genentech, Inc. from 2003 to 2019.
Education includes graduate studies at Georgetown University and undergraduate studies at the University of Mary Washington.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOME, INC. 0.03% | 2026-08-03 | 31,250 ( 0.03% ) | 711 250 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 2024-01-31 |
| Companies | Position | End |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-09-30 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2019-03-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mary Washington
University of Mary Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions